X-151404909-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_001017980.4(VMA21):c.164-7T>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 22)
Consequence
VMA21
NM_001017980.4 splice_region, splice_polypyrimidine_tract, intron
NM_001017980.4 splice_region, splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.003363
2
Clinical Significance
Conservation
PhyloP100: 1.32
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-151404909-T-G is Pathogenic according to our data. Variant chrX-151404909-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 208801.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-151404909-T-G is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.164-7T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000330374.7 | NP_001017980.1 | |||
VMA21 | NM_001363810.1 | c.329-7T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001350739.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.164-7T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001017980.4 | ENSP00000333255 | P1 | |||
VMA21 | ENST00000370361.5 | c.329-7T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000359386 | |||||
VMA21 | ENST00000477649.1 | n.244-7T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
X-linked myopathy with excessive autophagy Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 13, 2019 | This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect VMA21 protein function (PMID: 23315026). This variant has been observed in several individuals affected with X-linked myopathy with excessive autophagy (PMID: 23315026, 23850239, 24488655). ClinVar contains an entry for this variant (Variation ID: 208801). This sequence change falls in intron 2 of the VMA21 gene. It does not directly change the encoded amino acid sequence of the VMA21 protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 7
Find out detailed SpliceAI scores and Pangolin per-transcript scores at